QQ客服 官方微博 反馈留言

	Overall Survival Benefits for Combining Targeted Therapy as Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Published Data
	Yao, Yang; Qi, Wei-Xiang; Wang, Qiong; Jiang, Yan-Ling; Sun, Yuan-Jue; Tang, Li-na; He, Ai-na; Min, Da-liu; Lin, Feng; Shen, Zan
刊名	PLOS ONE
	2013
卷号	8期号:2
ISSN号	1932-6203
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3448542
专题	昆明医科大学
推荐引用方式 GB/T 7714	Yao, Yang,Qi, Wei-Xiang,Wang, Qiong,et al. Overall Survival Benefits for Combining Targeted Therapy as Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Published Data[J]. PLOS ONE,2013,8(2).
APA	Yao, Yang.,Qi, Wei-Xiang.,Wang, Qiong.,Jiang, Yan-Ling.,Sun, Yuan-Jue.,...&Shen, Zan.(2013).Overall Survival Benefits for Combining Targeted Therapy as Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Published Data.PLOS ONE,8(2).
MLA	Yao, Yang,et al."Overall Survival Benefits for Combining Targeted Therapy as Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Published Data".PLOS ONE 8.2(2013).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。